US Stock MarketDetailed Quotes

AUPH Aurinia Pharmaceuticals

Watchlist

7.950
+0.400+5.30%

Close Feb 28 16:00 ET

7.948
-0.002-0.03%

Post 18:29 ET

1.14BMarket Cap198.75P/E (TTM)

Aurinia Pharmaceuticals Key Stats

Aurinia Pharmaceuticals Q4 2024 Earnings Date

Currency：USDFeb 27, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	59.94M	59.87M	-77.50K
Miss Est.	+32.93%	+32.76%	-0.13%
EPS	-0.02	0.01	+0.03
Beat Est.	+91.63%	+105.56%	+162.89%

Analyst Rating

Buy

Feb 28, 2025

Aurinia Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 64.471M	--
--	2025/Q1	-- / 61.059M	--
Feb 27, 2025	2024/Q4	59.867M / 59.945M	--
Nov 7, 2024	2024/Q3	67.771M / 57.693M	--
Aug 1, 2024	2024/Q2	57.192M / 54.690M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 64.471M--

--2025/Q1-- / 61.059M--

Feb 27, 20252024/Q459.867M / 59.945M--

Nov 7, 20242024/Q367.771M / 57.693M--

Aug 1, 20242024/Q257.192M / 54.690M--

Unlock Free Earnings Estimates

Open Account

Aurinia Pharmaceuticals Earnings Reports

Aurinia Pharmaceuticals | 10-K: FY2024 Annual Report

Feb 27 06:13 ET

Aurinia Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 06:23 ET

Aurinia Pharmaceuticals | 8-K: Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS ® Growth and AUR200 Development

Nov 7, 2024 06:18 ET

Aurinia Pharmaceuticals | 8-K: AURINIA PHARMACEUTICALS REPORTS SECOND QUARTER AND SIX MONTHS 2024 FINANCIAL AND OPERATIONAL RESULTS

Aug 1, 2024 06:13 ET

AUPH Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aurinia Pharmaceuticals Q4 2024 Earnings Date

Aurinia Pharmaceuticals Earnings Estimates

Aurinia Pharmaceuticals Earnings Reports

Trending Stocks